glp 1 for mental health GLP-1s may improve some outcomes in addition to lowering body weight GLP-1RAs Reduce External Eating Behavior

Related Services at Leva Medical Frequently Asked Questions Retatrutide is the first triple-agonist therapy targeting GLP-1, GIP, and glucagon receptors , while Ozempic (semaglutide) only targets GLP-1 and Mounjaro (tirzepatide) targets GLP-1 + GIP

Acquisition of data: Ghaith, Johnson, El-Hajj, Atkinson

10.3389/fonc.2024.1384928 133

Rodents treated with GLP-1 receptor agonists demonstrated reduced joint inflammation, decreased synovial proliferation, and lower levels of inflammatory cytokines compared to untreated controls

Future studies should analyze the dermatologic side effects of these medications as consumers share concerns regarding their impact on the skin, the study authors conclude.

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers